机译:抗精神病药治疗对精神分裂症中白细胞介素-6 [IL-6]基因甲基化状态的影响
Department of Human Genetics National Institute of Mental Health and Neurosciences;
Translational Psychiatry Laboratory Neurobiology Research Centre National Institute of Mental;
Department of Human Genetics National Institute of Mental Health and Neurosciences;
Translational Psychiatry Laboratory Neurobiology Research Centre National Institute of Mental;
Translational Psychiatry Laboratory Neurobiology Research Centre National Institute of Mental;
Translational Psychiatry Laboratory Neurobiology Research Centre National Institute of Mental;
Translational Psychiatry Laboratory Neurobiology Research Centre National Institute of Mental;
Human Molecular Genetics Lab Rajiv Gandhi Centre for Biotechnology;
Department of Human Genetics National Institute of Mental Health and Neurosciences;
Translational Psychiatry Laboratory Neurobiology Research Centre National Institute of Mental;
Schizophrenia; IL-6; Promoter; Methylation; Inflammation; Antipsychotics;
机译:抗精神病药治疗对精神分裂症中白细胞介素-6 [IL-6]基因甲基化状态的影响
机译:抗精神病药对毒药 - 幼稚精神分裂症患者外周血单核细胞IL-6 / Stat3信号轴的影响
机译:白细胞介素-6基因启动子对冠状动脉粥样硬化患者IL-6 mRNA水平的白细胞介素-6基因启动子的关系
机译:生物标志物在脑脊液中发现精神分裂症和抗精神病药治疗诱导的体重增加。
机译:正畸牙移动过程中白细胞介素6(IL-6),可溶性糖蛋白130(sgp130)和可溶性白介素6受体(sIL-6R)的牙龈沟液(GCF)水平。
机译:白细胞介素-6(IL-6)启动子基因多态性(−174G C-572G C和-597G A)对年轻印度人IL-6血浆水平的影响及其对急性缺血性中风发展的影响
机译:白细胞介素-6基因多态性与抗精神病药物 - 精神分裂症患者海马体积的关系:差异易感性的证据?